Yahoo
Stockholm - Delayed Quote SEK

RaySearch Laboratories AB (publ) (RAY-B.ST)

202.80 +0.40 (+0.20%)
At close: October 30 at 12:59:58 PM GMT+1
Chart Range Bar
Loading chart for RAY-B.ST
  • Previous Close 202.40
  • Open 202.60
  • Bid 202.40 x --
  • Ask 203.40 x --
  • Day's Range 199.70 - 203.80
  • 52 Week Range 153.10 - 264.50
  • Volume 48,554
  • Avg. Volume 164,364
  • Market Cap (intraday) 6.044B
  • Beta (5Y Monthly) 0.87
  • PE Ratio (TTM) 32.60
  • EPS (TTM) 6.22
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 4.00 (1.98%)
  • Ex-Dividend Date May 8, 2026
  • 1y Target Est 297.50

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.

www.raysearchlabs.com

464

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

RAY-B.ST
9.17%
OMX Stockholm 30 Index (^OMX)
13.47%

1-Year Return

RAY-B.ST
8.77%
OMX Stockholm 30 Index (^OMX)
17.56%

3-Year Return

RAY-B.ST
164.75%
OMX Stockholm 30 Index (^OMX)
59.03%

5-Year Return

RAY-B.ST
247.08%
OMX Stockholm 30 Index (^OMX)
42.80%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 290.3M
Earnings 53.2M
Profit Margin 18.33%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
100M
200M
300M
12.0%
14.0%
16.0%
18.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

250.00
297.50 Average
202.80 Current
345.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.77%

  • Return on Assets (ttm)

    10.32%

  • Return on Equity (ttm)

    26.02%

  • Revenue (ttm)

    1.27B

  • Net Income Avi to Common (ttm)

    213M

  • Diluted EPS (ttm)

    6.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    213.1M

  • Total Debt/Equity (mrq)

    45.56%

  • Levered Free Cash Flow (ttm)

    130.91M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: